tiprankstipranks
Bioline RX Ltd Sponsored ADR (BLRX)
NASDAQ:BLRX
US Market
BLRX
Bioline RX Ltd Sponsored ADR
RESEARCH TOOLSreports
Want to see BLRX full AI Analyst Report?

Bioline RX Ltd Sponsored ADR (BLRX) Stock News & Sentiment

2,546 Followers
BioLineRx and Hemispherian Showcase New GLIX1 Data Ahead of ASCO 2026 as First-in-Human GBM Trial Enrolls
Premium
Company Announcements
BioLineRx and Hemispherian Showcase New GLIX1 Data Ahead of ASCO 2026 as First-in-Human GBM Trial Enrolls
2d ago
6K
BLRX
BioLineRx and Hemispherian Report Strong Preclinical GLIX1 Data in Temozolomide-Resistant Glioblastoma
Premium
Company Announcements
BioLineRx and Hemispherian Report Strong Preclinical GLIX1 Data in Temozolomide-Resistant Glioblastoma
5d ago
6K
BLRX
BioLineRx and Hemispherian Dose First Patient in Phase 1/2a GLIX1 Glioblastoma Trial
Premium
Company Announcements
BioLineRx and Hemispherian Dose First Patient in Phase 1/2a GLIX1 Glioblastoma Trial
26d ago
6K
BLRX
BioLineRx: Advancing GLIX1 and Motixafortide Pipeline with Strengthened IP and Legal Position Underpinning Buy Rating and $12 Target
Premium
Ratings
BioLineRx: Advancing GLIX1 and Motixafortide Pipeline with Strengthened IP and Legal Position Underpinning Buy Rating and $12 Target
2M ago
BLRX
BioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma
Premium
Company Announcements
BioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma
2M ago
6K
BLRX
Options Volatility and Implied Earnings Moves Today, March 23, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 23, 2026
2M ago
LAR
MBX
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
2M ago
AIR
CCL
More BLRX News >

BLRX News on the Web

BioLineRx and Hemispherian Report Strong Preclinical GLIX1 Data in Temozolomide-Resistant Glioblastoma
TipRanks News
Bearish
BioLineRx and Hemispherian report new GLIX1 anti-tumor effect in GBM
TipRanks News
Bullish
BioLineRx and Hemispherian Dose First Patient in Phase 1/2a GLIX1 Glioblastoma Trial
TipRanks News
Bearish
BioLineRx, Hemispherian: First patient dosed in Phase 1/2a Study of GLIX1
TipRanks News
Neutral
BioLineRx, Hemispherian initiate clinical trial of GLIX1
TipRanks News
Bullish
BioLineRx: Advancing GLIX1 and Motixafortide Pipeline with Strengthened IP and Legal Position Underpinning Buy Rating and $12 Target
TipRanks News
Bullish
BioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma
TipRanks News
Neutral
BioLineRx initiates Phase 1/2a study of GLIX1
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
BLRX
Sector Average
Media Buzz
This Week3 articles
Weekly Average0.5 articles
News Sentiment
This Week50%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BLRX’s Media Buzz Sentiment?
3 articles about BLRX were published this week. In an average week, 0.5 articles are published.
    What is BLRX’s weekly average amount of articles?
    In an average week, 0.5 articles about BLRX are published.
      What is BLRX’s News Sentiment?
      50% of articles about BLRX were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week